Johnson Investment Counsel’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,373
| Closed | -$215K | – | 848 |
|
|
2025
Q1 | $215K | Sell |
3,373
-15
| -0.4% | -$957 | ﹤0.01% | 734 |
|
|
2024
Q4 | $412K | Buy |
3,388
+240
| +8% | +$29.2K | ﹤0.01% | 566 |
|
|
2024
Q3 | $393K | Sell |
3,148
-200
| -6% | -$25K | ﹤0.01% | 563 |
|
|
2024
Q2 | $529K | Hold |
3,348
| – | – | 0.01% | 481 |
|
|
2024
Q1 | $433K | Sell |
3,348
-4
| -0.1% | -$518 | ﹤0.01% | 532 |
|
|
2023
Q4 | $323K | Hold |
3,352
| – | – | ﹤0.01% | 568 |
|
|
2023
Q3 | $406K | Sell |
3,352
-300
| -8% | -$36.4K | 0.01% | 497 |
|
|
2023
Q2 | $418K | Buy |
3,652
+19
| +0.5% | +$2.18K | 0.01% | 508 |
|
|
2023
Q1 | $501K | Hold |
3,633
| – | – | 0.01% | 458 |
|
|
2022
Q4 | $471K | Sell |
3,633
-1,200
| -25% | -$155K | 0.01% | 463 |
|
|
2022
Q3 | $534K | Sell |
4,833
-9,500
| -66% | -$1.05M | 0.01% | 425 |
|
|
2022
Q2 | $1.07M | Sell |
14,333
-1,948
| -12% | -$146K | 0.02% | 318 |
|
|
2022
Q1 | $1.27M | Buy |
+16,281
| New | +$1.27M | 0.02% | 306 |
|
|
2021
Q1 | – | Sell |
-1,500
| Closed | -$256K | – | 623 |
|
|
2020
Q4 | $256K | Buy |
+1,500
| New | +$256K | ﹤0.01% | 521 |
|